Bio-Rad Laboratories | BIO - Ebitda





Ebitda Veränderung Datum
Abbott USD 2.43B 844M 2026-03
Agilent USD 577M 77M 2026-06
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Bio Techne USD 115.94M 763K 2026-06
Bio-Rad Laboratories USD 595.3M 1.23B 2026-06
Bruker USD 143.2M 33.2M 2026-06
Charles River Laboratories USD 272.95M 43.14M 2026-06
Danaher USD 1.84B 81M 2026-06
General Electric Aerospace USD 3.06B 219M 2026-06
Illumina USD 330M 80M 2026-06
IQVIA Holdings USD 994M 62M 2026-06
Laboratory Of America USD 767.7M 162.1M 2026-06
Merck USD -1.54B 7.84B 2026-03
Mettler Toledo International USD 322.64M 43.66M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 648M 91M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 228.18M 44.73M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Siemens EUR 4.2B 644M 2026-06
Standard Biotools USD -8.01M 7.8M 2026-03
Thermo Fisher Scientific USD 3.55B 845M 2026-06
Tosoh JPY 39.13B 286M 2024-12
Waters USD 712M 545M 2026-06